[
  {
    "monograph_id": "EMA/HMPC/150848/2006",
    "herbal_substance": "Valeriana officinalis L.",
    "plant_part": "radix",
    "common_name": "Valerian root",
    "pharmacopoeia_name": "Valerianae radix",
    "status": "well-established use",
    "therapeutic_area": ["central nervous system"],
    "indications": [
      {
        "indication": "Relief of mild nervous tension and sleep disorders",
        "status": "well-established use",
        "evidence_level": "Clinical studies"
      }
    ],
    "posology": {
      "preparation": "Dry extract (ethanol 70% v/v)",
      "single_dose": "400-600 mg",
      "daily_dose": "400-600 mg",
      "duration": "2-4 weeks",
      "age_restriction": "Adults and adolescents over 12 years"
    },
    "contraindications": ["Hypersensitivity to the active substance"],
    "special_warnings": ["May impair ability to drive"],
    "interactions": [
      {
        "interacting_substance": "CNS depressants",
        "effect": "Additive sedative effect",
        "severity": "moderate"
      }
    ],
    "pregnancy_lactation": {
      "pregnancy": "Not recommended due to lack of data",
      "lactation": "Not recommended due to lack of data"
    },
    "adverse_reactions": [
      {
        "reaction": "Gastrointestinal disturbances",
        "frequency": "uncommon"
      }
    ],
    "pharmacology": {
      "mechanism": "GABAergic activity",
      "active_constituents": ["valerenic acid", "isovaleric acid"]
    },
    "publication_date": "2016-01-26"
  },
  {
    "monograph_id": "EMA/HMPC/321233/2012",
    "herbal_substance": "Ginkgo biloba L.",
    "plant_part": "folium",
    "common_name": "Ginkgo leaf",
    "status": "well-established use",
    "therapeutic_area": ["cognitive function", "peripheral circulation"],
    "indications": [
      {
        "indication": "Improvement of age-associated cognitive impairment",
        "status": "well-established use",
        "evidence_level": "Clinical trials"
      }
    ],
    "posology": {
      "preparation": "Dry extract (acetone-water)",
      "single_dose": "120-240 mg daily",
      "duration": "At least 8 weeks"
    },
    "contraindications": ["Hypersensitivity", "Pregnancy"],
    "interactions": [
      {
        "interacting_substance": "Anticoagulants",
        "effect": "Increased bleeding risk",
        "severity": "serious"
      }
    ],
    "quality_standards": {
      "marker_compounds": ["ginkgolides A, B, C", "bilobalide", "flavonoid glycosides"],
      "assay_requirements": "22-27% flavonoid glycosides, 5-7% terpene lactones"
    }
  },
  {
    "monograph_id": "EMA/HMPC/680615/2013",
    "herbal_substance": "Hypericum perforatum L.",
    "plant_part": "herba",
    "common_name": "St. John's wort",
    "status": "well-established use",
    "therapeutic_area": ["mental health"],
    "indications": [
      {
        "indication": "Treatment of mild to moderate depressive episodes",
        "status": "well-established use",
        "evidence_level": "Clinical trials"
      }
    ],
    "contraindications": ["Known photosensitivity", "Concurrent use with many medications"],
    "special_warnings": ["Significant drug interactions via CYP450"]
  }
]
